Sangamo Therapeutics Inc (SGMO) Event Aug. 04, 2022, 00:00 UTC (51% Neutral) SANGAMO THERAPEUTICS, INC. (SGMO) Reports Financial Results for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 12:22 p.m. 🏢 Sangamo Therapeutics Inc (SGMO) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Total Assets $721.92M $617.13M $104.80M +16.98% 📈 Total Liabilities $346.58M $298.85M $47.73M +15.97% 📉 Stockholders' Equity $375.34M $318.28M $57.06M +17.93% 📈 Operating Income/Loss $-95.00M $-91.00M $-4.01M -4.40% ↘️ R&D Expense $116.52M $118.60M $-2.08M -1.76% ↘️ Earningspersharebasic $-0.65 $-0.59 $-0.06 -10.17% 📉 Earningspersharediluted $-0.65 $-0.59 $-0.06 -10.17% 📉 📈 Financial Trend Analysis 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Sangamo Therapeutics Inc (SGMO) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document